2 Patents
- US119590832024Immunosuppression-reverting Oligonucleotides Inhibiting the Expression of CD39
Secarna Pharmaceuticals GmbH & Co. KG
0 cites - US116665952023Antisense Oligonucleotides for Inhibition of PD-L1 Expression and Treating Cancer
Secarna Pharmaceuticals GmbH & Co. KG
0 cites